These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Cross reactivity of schistosome antigens between Schistosoma mansoni and japonicum. Kitani K; Miura R; Iuchi M Tohoku J Exp Med; 1979 Feb; 127(2):151-6. PubMed ID: 760262 [TBL] [Abstract][Full Text] [Related]
85. The development of hepatic granulomas in 20 Krad irradiated Schistosoma mansoni cercaria vaccinated grivet monkeys (Cercopithecus aethiops aethiops). Torben W; Hailu A Exp Parasitol; 2007 Dec; 117(4):376-81. PubMed ID: 17603044 [TBL] [Abstract][Full Text] [Related]
86. [Dendritic cells and Th2 response induced by schistosome infection]. Zang W; Shen YJ; Cao JP Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):63-6. PubMed ID: 18637589 [TBL] [Abstract][Full Text] [Related]
87. Schistosomiasis vaccines: a response to a devils' advocate's view. Hagan P; Doenhoff MJ; Wilson RA; Al-Sherbiny M; Bergquist R Parasitol Today; 2000 Aug; 16(8):322-3. PubMed ID: 10900475 [No Abstract] [Full Text] [Related]
88. Vaccines and diagnostics for zoonotic schistosomiasis japonica. You H; McManus DP Parasitology; 2015 Feb; 142(2):271-89. PubMed ID: 25359506 [TBL] [Abstract][Full Text] [Related]
89. [The new generations of vaccines against parasites]. Wedrychowicz H Wiad Parazytol; 2000; 46(1):21-7. PubMed ID: 16886350 [TBL] [Abstract][Full Text] [Related]
90. Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons. Le L; Molehin AJ; Nash S; Sennoune SR; Ahmad G; Torben W; Zhang W; Siddiqui AA Pathology; 2018 Jun; 50(4):442-449. PubMed ID: 29739616 [TBL] [Abstract][Full Text] [Related]
91. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Kariuki TM; Farah IO; Wilson RA; Coulson PS Parasite Immunol; 2008 Oct; 30(10):554-62. PubMed ID: 18786069 [TBL] [Abstract][Full Text] [Related]
92. Vaccine development against schistosomiasis from concepts to clinical trials. Capron A; Capron M; Riveau G Br Med Bull; 2002; 62():139-48. PubMed ID: 12176856 [TBL] [Abstract][Full Text] [Related]
93. Schistosoma japonicum reveals distinct reactivity with antisera directed to proteases mediating host infection and invasion by cercariae of S. mansoni or S. haematobium. Chlichlia K; Schauwienold B; Kirsten C; Doenhoff MJ; Fishelson Z; Ruppel A Parasite Immunol; 2005 Mar; 27(3):97-102. PubMed ID: 15882236 [TBL] [Abstract][Full Text] [Related]
94. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Kariuki TM; Farah IO; Yole DS; Mwenda JM; Van Dam GJ; Deelder AM; Wilson RA; Coulson PS Infect Immun; 2004 Sep; 72(9):5526-9. PubMed ID: 15322059 [TBL] [Abstract][Full Text] [Related]
95. Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Wilson RA; Coulson PS Trends Parasitol; 2009 Sep; 25(9):423-31. PubMed ID: 19717340 [TBL] [Abstract][Full Text] [Related]
96. Immunopathogenesis of human schistosomiasis. Burke ML; Jones MK; Gobert GN; Li YS; Ellis MK; McManus DP Parasite Immunol; 2009 Apr; 31(4):163-76. PubMed ID: 19292768 [TBL] [Abstract][Full Text] [Related]
97. A look ahead in research and control of schistosomiasis. Cook JA; Mecaskey JW R I Med; 1992 Apr; 75(4):217-9. PubMed ID: 1600257 [No Abstract] [Full Text] [Related]
99. Schistosoma mekongi: a prominent neutrophil chemotactic activity of egg antigen with reference to that of Schistosoma japonicum. Owhashi M; Matsumoto J; Imase A; Kirinoki M; Kitikoon V; Chigusa Y; Matsuda H Exp Parasitol; 2005 Aug; 110(4):335-41. PubMed ID: 15893311 [TBL] [Abstract][Full Text] [Related]
100. Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica. Solomon JS; Nixon CP; McGarvey ST; Acosta LP; Manalo D; Kurtis JD Protein Expr Purif; 2004 Aug; 36(2):226-31. PubMed ID: 15249044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]